Azoospermia, Nonobstructive
18
3
5
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
11%
2 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
Maternal Inheritance of a Pathogenic MT-ND1 Mutation Causes Mitochondrial Dysfunction and Spermatogenic Failure in Men
Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells
Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm
Inhibin B/FSH Ratio as a Predictor of Testicular Pathology in NOA
Autologous Transplantation of Human Cryopreserved Testis Tissue
Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration
Management of Non Obstructive Azoospermia in Men
Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®
TeSE (Testicular Sperm Extraction) in Azoospermic Patients: m-TeSE vs. l-TeSE
Machine Learning Based-Personalized Prediction of Sperm Retrieval Success Rate
2015-Metabolomics&Microbiome-infertility
The Potential of Sperm Retrieved by Micro-TESE to Fertilize Vitrified/Warmed Oocytes
Hormonal Stimulation of Spermatogenesis
Seminal Level of Clusterin Before Testicular Sperm Extraction
The Effects of Intratesticular PRP Injection in Men With Azoospermia or Cryptozoospermia
Seminal TEX101 as a Predictor of Recovery of Spermatogenesis in Azoospermic Men With Palpable Varicocele
TESE and Non Obstructive Azoospermia
Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia.